Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

SIMPLE SUMMARY: Advanced hepatocellular carcinoma (HCC) is an aggressive liver cancer with limited treatment options and poor prognosis. Tumor-Treating Fields (TTFields) are electric fields that disrupt cancer cell division and are approved for glioblastoma and mesothelioma treatment. Laboratory res...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkika, Eleni, Grosu, Anca-Ligia, Macarulla Mercade, Teresa, Cubillo Gracián, Antonio, Brunner, Thomas B., Schultheiß, Michael, Pazgan-Simon, Monika, Seufferlein, Thomas, Touchefeu, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946145/
https://www.ncbi.nlm.nih.gov/pubmed/35326718
http://dx.doi.org/10.3390/cancers14061568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946145/
https://www.ncbi.nlm.nih.gov/pubmed/35326718
http://dx.doi.org/10.3390/cancers14061568

Ejemplares similares